Cryoglobulinemia future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 2: Line 2:
{{Cryoglobulinemia}}
{{Cryoglobulinemia}}


{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}
{{CMG}}; {{AE}} {{CZ}}


==Overview==
==Overview==

Latest revision as of 14:56, 15 June 2016

Cryoglobulinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryoglobulinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryoglobulinemia future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryoglobulinemia future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryoglobulinemia future or investigational therapies

CDC on Cryoglobulinemia future or investigational therapies

Cryoglobulinemia future or investigational therapies in the news

Blogs on Cryoglobulinemia future or investigational therapies

Directions to Hospitals Treating Cryoglobulinemia

Risk calculators and risk factors for Cryoglobulinemia future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Future or Investigational Therapies

  • In patients with acute, severe disease, plasmapheresis has been used in conjunction with high dose steroids and cytoxan.
    • Uncontrolled studies demonstrated a reduction in creatinine in up to 87% of patients.

References


Template:WikiDoc Sources